Anti-Tumor Necrosis Factor Treatment does not decrease the Risk of Type 2 Diabetes in Patients with Inflammatory Bowel Disease

Marie Villumsen*, Gry Poulsen, Nynne Nyboe Andersen, Mikael Andersson, Tine Jess, Kristine Højgaard Allin

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
14 Downloads (Pure)
Original languageEnglish
JournalClinical Gastroenterology and Hepatology
Volume21
Issue number12
Pages (from-to)3182-3184.e3
Number of pages6
ISSN1542-3565
DOIs
Publication statusPublished - Nov 2023

Cite this